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Abstract
BACKGROUND: We prospectively studied a group of patients with myocardial infarction (MI), who were candidates for surgical 
revascularization, to compare the efficacy of dobutamine gated myocardial SPECT with dobutamine stress echocardiography 
(DSE) for the detection of myocardial viability.
MATERIALS AND METHODS: We investigated 224 segments from 14 patients with MI using resting echocardiography and 
low dose dobutamine stress echocardiography as well as resting, low and high dose dobutamine stress 99mTc-Sestamibi 
gated SPECT. 
RESULTS: In total, 13 men and 1 women with a mean age 54.57 years (range, 43 to 71 years) entered the study. Of the 125 
dysfunctional segments, as assessed by ECG-gated examination, 53 (23.66% of total) were hypokinetic at rest, 64 (28.57% 
of total) were akinetic, and 8 (3.57% of total) were dyskinetic. The number of segments with resting wall motion abnormality 
(considered viable by low dose dobutamine ECG-gated examination) was significantly greater than those showing a contractile 
improvement in response to dobutamine in echocardiography (39.2% versus 32.8%, respectively, p < 0.05). In addition, in 
high dose ECG-gated examination, 42 of the 125 dysfunctional segments (33.6%) were viable. In general, the methods were 
well correlated.
CONCLUSION: We found a good agreement between low dose dobutamine gated SPECT and stress dobutamine echocar-
diography for the detection of inotropic reserve in infarcted areas. 
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Background
Differentiation of dysfunctional but viable myocardium from 
irreversibly damaged scar tissue has important clinical implica-
tions for patients with chronic myocardial infarction and impaired left 
ventricular function [1]. Therefore, several imaging techniques with 
different approaches are used to identify viable regions with severely 
depressed function [1, 2]. 
Dobutamine stress echocardiography (DSE), nuclear imag-
ing by single photon emission computed tomography (SPECT), 
magnetic resonance imaging (MRI), positron emission tomography 
(PET) with F-18 fluorodeoxyglucose (18F-FDG), and tissue Dop-
pler imaging (TDI) have been proposed as effective techniques for 
the evaluation of myocardial viability. Among these, DSE and MPI 
SPECT have been widely available in routine practice [3]. 
Gated myocardial SPECT is recommended for simultane-
ous assessment of perfusion and function, and permits objective 
assessment of regional function [1, 4]. Although, there are some 
studies showing that dobutamine gated myocardial SPECT agreed 
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well with DSE for the identification of viability in infarcted areas, the 
efficacy of the application of myocardial gated SPECT in this issue 
has not yet been fully investigated [1, 5–7].
The main purpose of this study was to compare the accuracy 
of low dose dobutamine stress gated myocardial SPECT with 
low-dose dobutamine stress echocardiography (DSE) for the 
identification of viable myocardium in patients with previous myo-
cardial infarction.
Materials and methods
Participants
Twenty-two candidates for coronary artery bypass graft sur-
gery because of stable left ventricular dysfunction were enrolled 
in this study. The inclusion criteria were as following: one or more 
myocardial wall motion abnormality on preoperative resting echo-
cardiography (16-segment left ventricular model), absence of 
recent episodes of unstable angina, absence of significant valvular 
disease and the presence of a normal sinus rhythm. Of these, 
3 patients were found to be subsequently ineligible; 5 pa-
tients agreed to join in the study, but did not attend their appoint-
ment for five examinations; 14 subjects fulfilled the eligibility criteria 
and participated in the study. 
All patients had undergone resting echocardiography and low 
dose dobutamine stress echocardiography as well as resting, low 
and also high dose dobutamine stress 99mTc-Sestamibi gated 
SPECT in short intervals within 2 weeks. 
The study complies with the declaration of Helsinki and was ap-
proved by the institutional ethics committee. All patients signed 
a written informed consent.
Imaging protocols
Dobutamine stress echocardiography
Beta-blockers, calcium channel blockers and nitrates were 
discontinued at least 2 days before DSE.
Echocardiography was performed with a 3.5 MHz transducer 
under resting conditions and during each dobutamine infusion 
step. After baseline echocardiography, dobutamine was delivered 
intravenously beginning at 5 mg/kg/min for three minutes, followed 
by 2.5 mg/kg/min increments every three minutes to a maximum of 
10 mg/kg/min. Blood pressure was measured periodically, and the 
12-lead ECG was continuously monitored throughout the study and 
during the recovery phase. The test was aborted if the patient expe-
rienced a severe hypotensive or hypertensive response, prolonged 
angina, significant electrocardiographic changes and arrhythmias, 
appearance of new wall motion abnormalities in at least two seg-
ments, achievement of 85% of the maximum age-predicted heart 
rate, or when the protocol was completed. Echocardiographic im-
ages were analyzed off-line and a 16-segment model was used [8, 9]. 
Wall motion, including wall thickening, of every segment 
was scored with a 4-point scoring system, from normal wall mo-
tion to dyskinesia. 
Normal, hypokinetic, akinetic, and dyskinetic segments were 
scored from 1 to 4, respectively. We defined a segment as hy-
pokinetic (HK) in the existence of minimal wall thickening with 
an inadequate inward motion of < 2 mm, as akinetic in the lack of 
systolic wall motion, and as dyskinetic in the existence of systolic 
outward wall motion with thinning.
Viability was mentioned to be present in a dysfunctional 
segment when wall motion showed an improvement of at least 
one point of the scoring system during the infusion of low dose 
dobutamine.
All studies were read by an experienced investigator who 
was unaware of the clinical information and the radionuclide 
information. 
In each patient, the wall motion score index, which is the sum 
of the segment scores divided by 9, was acquired for baseline 
and dobutamine echocardiograms [10]. The difference between 
baseline and the dobutamine wall motion score was defined as the 
contractile reserve [10]. 
Low and high dose dobutamine protocol SPECT
A low dose, incremental infusion of dobutamine was injected 
intravenously at a starting dose of 5 mg/kg/min incremented by 
2.5 mg/kg/min at 3-min intervals. ECG-gated SPECT was then 
carried out during the dobutamine infusion (10 mg/kg/min). In addi-
tion, TNG was administered in another hand via a serum micro-set 
accompanied with low dose dobutamine infusion. Moreover, for 
high dose dobutamine protocol graded infusion of dobutamine 
was injected intravenously at a starting dose of 10 mg/kg/min and 
incremented by 5 mg/kg/min at 3-min intervals and then increased 
to 20 mg/kg/min. The test was aborted in the case of hypotension, 
angina, and significant ventricular arrhythmia.
The patients underwent incessant ECG monitoring, and blood 
pressure was recorded at 1 min intervals using an automated cuff.
SPECT acquisition and processing 
Patients were instructed to fast for at least 4 h before the study. 
Beta-blockers and calcium channel blockers were discontinued 
48 h, and the patients were advised not to take caffeine or amino-
phylline 24 h before the test. 
A commercial sestamibi kit (AEOI, Tehran, Iran) was used and 
the labeling and quality control procedures were performed ac-
cording to the manufacturer’s instructions. 
The first gated myocardial SPECT was done after the injection 
of 740–925 MBq 99mTc-sestamibi at rest. The second and third 
gated SPECT were conducted after low or high dose dobutamine 
infusion, respectively. In all three protocols, radiotracer was admin-
istered intravenously; 30 min after injection of 99mTc-sestamibi, 
the patients were requested to eat a fatty snack to accelerate 
hepatobiliary excretion of the radiotracer. After 60 minutes of radio-
tracer administration to patients, image acquisition was performed 
using a rotating, dual head gamma camera (Siemens, Germany) 
equipped with a low-energy high resolution (LEHR) parallel hole 
collimator in supine position. A 20% window around the 140 keV 
energy peak of 99mTc-sestamibi was applied. 
Thirty-two azimuth images, 60 s/projection, were acquired 
in a 180º circular orbit, beginning from 45º right anterior oblique 
to 135º left posterior oblique with step and shoot acquisition on 
a 64 × 64 × 16 matrix and 38.5 cm detector mask (1.22 zoom) 
using a gated mode with prefixed R–R interval at a rate of eight 
frames per cardiac cycle and beat acceptance window of 40%. 
The raw data from stress acquisition were prefiltered by ramp and 
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then by Butterworth filters Filtered back-projected data was rebuilt 
into short-axis, vertical long-axis and horizontal long-axis slices. 
An expert nuclear physician used the cine display of the rotating 
planar projections to evaluate sub-diaphragmatic activities, at-
tenuations and patient motion to make the best of the technical 
quality of the images.
SPECT Image Interpretation
The interpretation of the images was based on short-axis slices, 
longitudinal slices, and transverse long-axis slices [9]. The analy-
sis was performed visually with the help of quantitative measure-
ment. For SPECT evaluation, the polar map displays were divided 
into 16 segments, matching with the echocardiographic ones. 
Endocardial wall motion was assessed visually and scored from 1 
to 4 as normal, hypokinetic, akinetic, and dyskinetic respectively. 
Hypokinetic areas with a ≥ 1 point improvement in the score were 
considered as viable myocardium. Moreover, we used the wall 
motion score indexes (WMSIs) in three ECG-gated examinations. 
The gated image sets were read independently by 2 expert 
observers who were unaware of patient identity or the results of 
DSE. Furthermore, segment tracer activity was scored by 2 us-
ing a 5-point scoring scheme: 0 — normal, 1 — mildly reduced, 
2 — moderately reduced, 3 — severely reduced, and 4 — absent 
uptake [11]. Discrepancies were resolved by consensus.
The extent of infarct (expressed as the total number of seg-
ments with abnormal uptake), and the severity index of the infarct 
(calculated as the number of segments with severely decreased 
99mTc-sestamibi uptake divided by the total number of segments with 
abnormal uptake) were determined for each infarct zone [10].
Statistical analysis
Continuous variables are expressed as mean ± SD, and cate-
gorical variables as the absolute values and percentages. The cor-
relation between modalities for the assessment of myocardial seg-
ment viability was expressed as value of Kappa (k). A chi-squared 
test was used to compare the statistical parameters of this tech-
nique. A p-value < 0.05 was considered statistically significant. 
Statistical analysis was performed using an IBM computer and 
PASW software, version 18.0 (SPSS, Inc., Chicago, IL).
Results
In total, 14 patients constituted the final study population (mean 
age: 54.57 years ranging from 43 to 71). Thirteen patients were 
men and one was woman. Median angiographic left ventricular 
ejection fraction was 22.5% (interquartile range, 18.75–28.75%). 
Six patients had two-vessel disease, defined as diameter steno-
sis of a major coronary artery of > 50%; and eight patients had 
three-vessel disease. 
Mean left ventricular ejection fraction was 24.00% (19.25–
–31.50%) as measured by quantitative gated SPECT ima-
ges was considerably increased following low and high dose 
dobutamine infusion (Table 1). 
For analysis, a total of 224 myocardial segments from the 
14 patients were evaluated. Regional contractile function, as as-
sessed by resting ECG-gated examination, demonstrated normal 
contraction in 99 (44.19%) segments and abnormal contraction in 
125 (55.80%) segments. We excluded the 99 normal segments. 
The remaining 125 dysfunctional regions were subjected to further 
analysis. Of the 125 dysfunctional segments, 53 (23.66% of total) 
were hypokinetic at rest, 64 (28.57% of total) were akinetic, and 8 
(3.57% of total) were dyskinetic.
In stress echocardiography findings, 41 of the 125 dysfunctional 
segments (32.8%) were viable. Viability was found in 28/49 (57.14%) 
hypokinetic and 13/70 (18.57%) akinetic regions. All 6 dyskinetic 
segments were nonviable.
In low dose ECG-gated examination findings, 49 of the 125 
dysfunctional segments (39.2%) were viable. Viability was found 
in 43/53 (81.13%) hypokinetic and 6/64 (9.37%) akinetic regions. 
All 8 dyskinetic segments were nonviable (Figure 1).
In high dose ECG-gated examination findings, 42 of the 125 
dysfunctional segments (33.6%) were viable. Viability was found in 
33/53 (62.26%) hypokinetic and 3/64 (4.68%) akinetic regions. All 
8 dyskinetic segments were nonviable (Figure 1).
The mean baseline wall motion score index (WMSI) in echocar-
diography was [median 0.35, interquartile range (0.32–0.46)]. The 
dobutamine infusion protocol was concluded in all patients without 
complications and mean WMSI in low dobutamine echocardiog-
raphy was 0.34, 0.30–0.37. According to the comparison between 
baseline and dobutamine WMSI, 3 patients showed no change in 
contractile reserve, and the remaining 11 had a decrease in WMSI 
(0.00, 01–0.10). All 11 patients with a significant difference in the 
dobutamine-induced change in WMSI showed significant LVEF 
improvement (> 5%). 
The mean baseline WMSI in gated myocardial SPECT was [me-
dian 0.37, interquartile range (0.34–0.41)]. The low dobutamine 
infusion protocol was conducted in all patients without compli-
cations and mean WMSI was 0.37, 0.32–0.37. According to the 
comparison between baseline and dobutamine WMSI, 3 pa-
tients showed no change in contractile reserve, and the remaining 
11 had a decrease in WMSI (0.00, 0.01–0.08). All 11 patients with 
a significant difference in the dobutamine-induced change in WMSI 
showed significant LVEF improvement (> 5%). 
In addition, high dobutamine infusion protocol was conducted 
in all patients which angina occurred in 7 patients during the test. 
The median WMSI was 0.37, 0.33–0.40. Five patients showed new 
or worsening of preexisting wall motion abnormalities and higher 
WMSI in high-dose dobutamine infusion protocol compared with 
Table 1. Patients’ hemodynamics during five different modalities
RE LDDSE RGMSPECT LDDMGSPECT HDDMGSPECT
SBP [mm Hg] 105.71 ± 17.18 110.00 ± 17.32 102.27 ± 13.66 107.72 ± 18.62 119.09 ± 23.75
DBP [mm Hg] 68.57 ± 10.69 72.85 ± 12.53 76.36 ± 14.15 74.54 ± 14.39 79.54 ± 12.73
HR 76.14 ± 12.83 80.28 ± 15.85 79.27 ± 18.18 94.36 ± 18.09 121.81 ± 23.90
RE — rest echocardiography; LDDSE — low dose dobutamine stress echocardiography; RGMSPECT — rest gated myocardial SPECT; LDDMGSPECT — low dose dobutamine myocardial 
gated SPECT; HDDMGSPECT — high dose dobutamine myocardial gated SPECT
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Figure 1. Five echocardiography and myocardial perfusion imaging examinations of a 64-year-old patient with two-vessel disease. Angiographic 
left ventricular ejection fraction was 15%. There are severe perfusion defects of mid-anterior and apex segments with extension to anteroseptal 
and inferior walls on the resting ECG-gated myocardial perfusion SPECT imaging (A). After low (B, C) and high (D, E) dose dobutamine infusion 
during ECG-gated myocardial perfusion imaging acquisition, there is no clear evidence of improvement of the wall motion and thickening in the 
aforementioned regions.  
There is also moderate hypoactivity of lateral and anterolateral walls which is normalized on the delayed views. The rest of left ventricle myocardium 
shows partial response to dobutamine infusion. The examination demonstratedated non-viable tissues in apex, apical parts of the inferior and 
anteroseptal walls and mid-anterior segment. In addition, viable but ischemic myocardium (hibernated tissue) was observed in the remaining parts 
of the anteroseptal and inferior walls (except for its apical parts) and anterobasal segment.  
Dobutamine stress echocardiography was done without any complication. It showed non-viable myocardium in anteroseptal, mid anterior, septum, 
anterior and apex. 
A
B
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Table 2. Association between the number of abnormal perfusion segments and the severity index of the infarct variables with wall motion index 
score in five different examinations
RE P value LDDSE P value RGM-
SPECT
P value LDDMG-
SPECT
P value HDDMG-
SPECT
P value 
Number of abnormal 
segments
0.733 0.002* 0.123 0.66 0.895 0.000* 0.106 0.70 0.178 0.52
Severity index 0.118 0.67 0.654 0.008 0.043* 0.87 0.82 0.000* 0.387 0.15
*Spearman’s linear correlation coefficient
**The values were significant (p < 0.05)
RE — rest echocardiography; LDDSE — low dose dobutamine stress echocardiography; RGMSPECT — rest gated myocardial SPECT; LDDMGSPECT — low dose dobutamine myocardial 
gated SPECT; HDDMGSPECT — high dose dobutamine myocardial gated SPECT
Figure 1. E
low-dose dobutamine infusion protocol, whereas 3 patients did 
not show any change in these two protocols. On the other hand, 
6 cases showed less WMSI in high dobutamine infusion protocol 
and showed significant LVEF improvement (> 5%). 
The median number of abnormal segment was 6.50 (6.00– 
–11.25) and the severity index of the infarct ranged from 0 to 1.00, 
with a median of 0.66 (0.36–1.00). The number of abnormal seg-
ments was associated with WMSI in echocardiography and gated 
examinations at rest whilst severity index of the infarct was associ-
ated with low-dose dobutamine echocardiography and gated ex-
aminations. In addition, the number of abnormal segments and the 
severity index of the infarct did not show any association with WMSI 
in high dose dobutamine gated examination (p > 0.05) (Table 2). 
In general, the methods were well correlated (Table 3). The 
number of segments with resting wall motion abnormality con-
sidered viable by low dose dobutamine gated was significantly 
greater than those showing a contractile improvement in response 
to dobutamine in echocardiography(39.2% versus 32.8%, respec-
tively, p < 0.05). 
Discussion
The assessment of residual viability in regions with chronic con-
tractile dysfunction is important for the prediction of improvement 
after revascularization [1, 12]. Gated SPECT has been applied for 
the objective assessment of left ventricular function [13, 14]. We 
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have applied gated SPECT for the assessment of regional function 
under low-dose dobutamine infusion. In this study, a head-to-head 
comparison of the individual segments showed a 77% agreement 
between low-dose dobutamine stress echocardiography and 
ECC-gated myocardial SPECT. This finding is consistent with the 
previous report showing good agreement between DS SPECT and 
DSE in the recognition of inotropic reserve in infarcted areas [13]. 
Panza et al. [4] mentioned 68% agreement between DSE and thal-
lium scan and Bax et al. [1] found 72% agreement between DSE 
and technetium scan. However, the prior studies did not analyze 
these results with other methods of viability, such as PET measure-
ments of viability or functional recovery.
We observed discordance between the two methods in both 
AK and HK segments which found to be viable by 99mTc-sestamibi 
imaging SPECT, but did not show contractile reserve by DSE. In 
other words, LDD MPI SPECT (matched for echocardiographic 
segments) indicated the presence of viable myocardium more 
frequently than did LDDE in both segments.
Similar results were reported by Panza et al. [4] who tested 
201thallium imaging with dobutamine echocardiography, and 
demonstrated that a large number of segments with 201 thallium 
uptake may lack contractile reserve. The difference may arise 
from the mechanisms of the detection of myocardial viability by 
the two modalities; the cellular processes dependable for a posi-
tive inotropic response to adrenergic stimulation require a higher 
degree of myocyte functional integrity than those responsible for 
thallium uptake [4]. 
Schinkel et al. reported 17 direct comparative studies with dis-
similar settings that applied stress echocardiography and perfusion 
imaging in the same patients [1]. The study depicted that both me-
thods are helpful for the evaluation of patients with chronic coronary 
artery disease, although small differences between their accuracy 
are reported in different settings. They presented that to evaluate 
myocardial viability after acute infarction, the techniques seem to 
be equally sensitive, whereas stress echocardiography is more 
specific [6, 9].
A previous study was performed to compare dobutamine 
stress echocardiography and myocardial perfusion scan to detect 
viable myocardium in 46 patients with coronary artery disease 
and low ejection fraction. They showed that the proportion of seg-
ments showing a positive response to dobutamine is significantly 
lower than those with technetium uptake [7]. This finding was ob-
served in the non-gated MPI SPECT study while this study was done 
by gated MPI SPECT. 
Low-dose dobutamine echocardiography has been used 
as an effective method for evaluating myocardial viability. 
This method can predict the recovery of regional function after 
revascularization with sensitivities ranging from 74% to 92% and 
specificities ranging from 74% to 96% [1, 2, 14]. Previous stu-
dies comparing nuclear modalities with DSE confirmed the high 
sensitivity and high negative predictive value of PET and thallium 
SPECT imaging [6, 15, 16]. In contrast, DSE was found to be 
slightly less sensitive but more specific for predicting functional 
improvement [3]. The sensitivities was 78% for DSE% vs. 76% for 
dobutamine myocardial SPECT, and the specificities was 96% for 
DSE vs. 100% for dobutamine myocardial SPECT. Therefore, DS 
SPECT was relatively sensitive and highly specific in predicting 
functional recovery [1].
Although FDG PET is considered the most reliable method for 
the determination of viability, it is not widely available. In addition, 
using FDG PET to diabetic and glucose-intolerant patients may 
develop some difficulties [5].
The echocardiographic approaches are attractive from both 
an acquisition time and an economic point of view. However, 
echocardiography is not suitable for obese or elderly patients with 
lung disease [6]. On the other hand, DS SPECT can be performed 
in almost every patient regardless of body size or age. In addition, 
because of availability of objective assessment with SPECT, gated 
SPECT can be used to evaluate regional wall motion, even in are-
as inadequately assessed by echocardiography. Thus, LDD MPI 
SPECT is a practical protocol that improves the detection of viability 
by simultaneous myocardial perfusion and motion analysis in ad-
dition to coronary flow reserve assessment in one study. Moreover 
no extra imaging time or radioactivity is required compared with 
the routine protocol [17, 18]. 
Meanwhile, there are some issues which need to be addressed 
in further studies. Firstly, in this study and most other studies, 
viable myocardium was considered as myocardium that depicted 
dysfunction at rest which gets better in function after revascu-
larization (contractile reserve) [19]. But, we should accept the fact 
that myocardial viability explains myocardial cells that are alive, 
whether applied to a myocyte or to a segment of the myocardium, 
implies nothing regarding contractile state. 
Secondly, although sensitivity and specificity of all modali-
ties have been assessed by different investigations, there is no 
general consensus regarding the sufficient number of viable seg-
ments to forecast a better outcome after revascularization. Thirdly, 
the end point of all of these investigations was functional improve-
Table 3. Agreement rate among rest and low dose dobutamine stress echocardiography as well as rest, low dose and high dose dobutamine 
stress ECG-gated myocardial perfusion imaging in detection of viability of different functioning segments
RE LDDSE RGMSPECT LDDMGSPECT HDDMGSPECT
RE — 0.59 (0.51–0.68) 0.82 (0.76–0.89) 0.63 (0.55–0.71) 0.57 (0.49–0.65)
LDDSE 0.59 (0.51–0.68) — 0.52 (0.44–0.61) 0.77 (0.70–0.84) 0.55 (0.47–0.64)
RGMSPECT 0.82 (0.76–0.89) 0.52 (0.44–0.61) — 0.65 (0.57–0.72) 0.68 (0.61–0.76)
LDDMGSPECT 0.63 (0.55–0.71) 0.52 (0.44–0.61) 0.65 (0.57–0.72) — 0.75 (0.67–0.83)
HDDMGSPECT 0.57 (0.49–0.65) 0.55 (0.47–0.64) 0.68 (0.61–0.76) 0.75 (0.67–0.83) —
*Spearman’s linear correlation coefficient
**All the values were significant (p < 0.05)
RE — rest echocardiography; LDDSE — low dose dobutamine stress echocardiography; RGMSPECT — rest gated myocardial SPECT; LDDMGSPECT — low dose dobutamine myocardial 
gated SPECT; HDDMGSPECT, high dose dobutamine myocardial gated SPECT
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ment and it is questionable whether other main items such as the 
prevention of ventricular remodeling and also life-threatening 
arrhythmias are better predicted by these modalities.
Study limitations
The most important limitation of this study was that we could 
not follow our patients after coronary artery bypass surgery. Echo-
cardiographic and scintigraphic tests after revascularization could 
determine the statistical parameters of each method. In addition, 
although a similar 16-segment model was applied for DSE and 
SPECT data, misalignment may have affected the results.
The next limitation was the limited number of dysfunctional seg-
ments included in the present study, although our analysis included 
224 segments. Therefore, these findings should be validated in 
larger and well-designed studies. 
Conclusions
This study demonstrated a good agreement between low dose 
dobutamine gated SPECT and low dose dobutamine stress echo-
cardiography for the detection of inotropic reserve in infarcted areas. 
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